Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Kinki University is currently managing 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 2 distinct art units, which indicates that the university's research is being evaluated by different specialized groups. The involvement of 2 distinct examiners means that the prosecution of these matters is subject to 2 different sets of examiner perspectives and timelines. This distribution suggests a varied technical focus within the university's pending patent applications.
The busiest examiner for this portfolio is HUANG, GIGI GEORGIANA, who is responsible for 1 busiest examiner pending office action. This 1 busiest examiner pending office action is part of the 2 pending office actions currently active for the university. Because the workload is split between 2 distinct examiners and 2 distinct art units, the university's patent strategy is not reliant on a single individual's review. For a practitioner, this requires a strategy that accounts for the specific nuances of 2 distinct examiners in the Biotechnology & Pharmaceuticals field. The presence of 2 pending office actions ensures that the university's intellectual property efforts are moving forward on multiple fronts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUANG, GIGI GEORGIANA | 1 | 31.8% | +30.8% |
| SUN, GEORGE | 1 | 69.1% | +34.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18268052 | EASY-ASSEMBLY BED, MULTIPURPOSE TABLE, AND TRANSPORTATION LIGHTWEIGHT BOARD | SUN, GEORGE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18253096 | EYEDROPS FOR AMELIORATING OR PREVENTING RETINAL CIRCULATION DISORDER AND RETINAL NEUROVASCULAR COUPLING DISORDER | HUANG, GIGI GEORGIANA | — |
| 18268052 | EASY-ASSEMBLY BED, MULTIPURPOSE TABLE, AND TRANSPORTATION LIGHTWEIGHT BOARD | SUN, GEORGE | — |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| 3673 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18253096 | EYEDROPS FOR AMELIORATING OR PREVENTING RETINAL CIRCULATION DISORDER AND RETINAL NEUROVASCULAR COUPLING DISORDER | HUANG, GIGI GEORGIANA | 1613 | §103 | Final Rejection | — | Pending | Aug 23, 2023 |
| 18268052 | EASY-ASSEMBLY BED, MULTIPURPOSE TABLE, AND TRANSPORTATION LIGHTWEIGHT BOARD | SUN, GEORGE | 3673 | §103§112 | Non-Final OA | — | Pending | Jun 16, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial